THERANEXUS: THX Pharma Announces the Appointment of Julien Veys as Deputy Chief Executive Officer

Lyon, France - January 7, 2026, 8:00 a.m. CET - The Board of Directors of THX Pharma (Theranexus), a pharmaceutical company specializing in rare neurological diseases, today announces the appointment ...
Actusnews

THX Pharma announces the publication of its letter to shareholders

Lyon, France – January 8, 2025, 6:00 PM CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces the publication of its ...